Renquan Lu

2PUBLICATIONS
0CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 02, 2021
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer.

Yixuan Liu, Keyu Zhu, Xiaolin Guan

|Sep 18, 2021
Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin.

Jing Zhang, Suhong Xie, Lei Zhou

Pageof 1

Frequent Collaborators